Research Topics
| C C EarleSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Follow-up of patients with curatively resected colorectal cancer: a practice guidelineAlvaro Figueredo
Hamilton Regional Cancer Centre McMaster University, Hamilton, Ontario, Canada
BMC Cancer 3:26. 2003..A systematic review was conducted to evaluate the literature regarding the impact of follow-up on colorectal cancer patient survival and, in a second phase, recommendations were developed...
Identifying potential indicators of the quality of end-of-life cancer care from administrative dataCraig C Earle
Division of Population Sciences Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 21:1133-8. 2003..To explore potential indicators of the quality of end-of-life services for cancer patients that could be monitored using existing administrative data...
Failing to plan is planning to fail: improving the quality of care with survivorship care plansCraig C Earle
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 24:5112-6. 2006..This article reviews the elements of the proposed survivorship care plan and discusses areas of research and development needed to make them part of standard oncology practice...
Cancer physicians' attitudes toward colorectal cancer follow-upC C Earle
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Ann Oncol 14:400-5. 2003..The optimal follow-up strategy for colorectal cancer is unknown...
Influenza vaccination in elderly patients with advanced colorectal cancerCraig C Earle
Department of Adult Oncology, Dana Farber Cancer Institute, and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Clin Oncol 21:1161-6. 2003..To examine influenza vaccination use in patients undergoing chemotherapy for advanced cancer...
Quality of non-breast cancer health maintenance among elderly breast cancer survivorsCraig C Earle
Center for Outcomes and Policy Research, Dana Farber Cancer Center, 44 Binney St, Boston 02115, USA
J Clin Oncol 21:1447-51. 2003..To assess the quality of preventive health care, the role of health care participation, and the patient and provider characteristics associated with high-quality care for breast cancer survivors...
Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectivenessMonika K Krzyzanowska
Center for Outcomes and Policy Research, Dana Farber Cancer Institute, 44 Binney St, 454 STE 21 24, Boston, MA 02115, USA
J Clin Oncol 21:3409-14. 2003..To evaluate the use and effectiveness of cancer-directed therapy in elderly patients with locally advanced pancreatic cancer (LAPC)...
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patientsCraig C Earle
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Natl Cancer Inst 98:172-80. 2006..e., better outcomes). We examined associations between physician specialty and outcomes in a population-based cohort of elderly ovarian cancer surgery patients...
Evaluating claims-based indicators of the intensity of end-of-life cancer careCraig C Earle
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Int J Qual Health Care 17:505-9. 2005..To evaluate measures that could use existing administrative data to assess the intensity of end-of-life cancer care...
Trends in the aggressiveness of cancer care near the end of lifeCraig C Earle
MSc, Center for Outcomes and Policy Research, Dana Farber Cancer Center, 44 Binney St, 454 STE 21 24, Boston, MA 02115, USA
J Clin Oncol 22:315-21. 2004..To characterize the aggressiveness of end-of-life cancer treatment for older adults on Medicare, and its relationship to the availability of healthcare resources...
Two schedules of second-line irinotecan for metastatic colon carcinomaCraig C Earle
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
Cancer 101:2533-9. 2004....
Identifying cancer relapse using SEER-Medicare dataCraig C Earle
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Med Care 40:IV-75-81. 2002..Linking administrative data to registry data, as in the creation of the SEER (Surveillance, Epidemiology, and End Results) and Medicare data set, can provide the ability to infer the occurrence of relapse in selected situations...
Long term care planning for cancer survivors: a health services research agendaCraig C Earle
Center for Outcomes and Policy Research, Dana Farber Cancer Center, 44 Binney St, SM 271, Boston, MA 02115, USA
J Cancer Surviv 1:64-74. 2007..The IOM stated that survivorship care plans 'have strong face validity and can reasonably be assumed to improve care unless and until evidence accumulates to the contrary.'..
Under use of necessary care among cancer survivorsCraig C Earle
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 101:1712-9. 2004..Special attention and education are needed to ensure that survivors receive optimal medical services...
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysisC C Earle
Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 19:1064-70. 2001..To compare the effectiveness of chemotherapy given to elderly patients in routine practice for stage IV non-small-cell lung cancer (NSCLC) with the efficacy observed in randomized trials...
Who gets chemotherapy for metastatic lung cancer?C C Earle
Center for Outcomes and Policy Research, Department of Adult Oncology Dana Farber Cancer Institute, Boston, MA 02115, USA
Chest 117:1239-46. 2000..To determine the prevalence and factors associated with chemotherapy use in elderly patients presenting with advanced lung cancer...
Systematic overview of cost-utility assessments in oncologyC C Earle
Center for Outcomes and Policy Research, Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 18:3302-17. 2000..We critically reviewed the CUA literature and its role in informing clinical oncology practice, research priorities, and policy...
Impact of referral patterns on the use of chemotherapy for lung cancerCraig C Earle
Center for Outcomes and Policy Research, Dana Farber Cancer Center, Boston, MA 02115, USA
J Clin Oncol 20:1786-92. 2002..To determine the extent to which unexplained variation in the use of chemotherapy for advanced lung cancer is due to access to oncologists' services as opposed to treatment decisions made after seeing an oncologist...
An assessment of methods to combine published survival curvesC C Earle
University of Ottawa and Ottawa Regional Cancer Centre, Ontario, Canada
Med Decis Making 20:104-11. 2000..To assess the accuracies of different techniques for combining published survival curves, for use in disease modeling applications...
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trialsC C Earle
Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Eur J Cancer 35:1059-64. 1999..Continued trials to find and confirm an effective adjuvant strategy are warranted...
Mental health service utilization among long-term cancer survivorsCraig C Earle
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
J Cancer Surviv 1:156-60. 2007..Although generally well-adjusted, a subset of cancer survivors have been observed to experience ongoing psychological distress. There has been little study of mental health care utilization among cancer survivors, however...
Outcomes research in oncology: history, conceptual framework, and trends in the literatureS J Lee
Center for Outcomes and Policy Research, Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Natl Cancer Inst 92:195-204. 2000..We suggest that as different branches of investigation develop their own literature and methodology-in effect, outgrowing the generic label of outcomes research-they become identified by separate, more precise terms...
Cost of combined modality interventions for stage III non-small-cell lung cancerW K Evans
University of Ottawa, Ontario, Canada
J Clin Oncol 15:3038-48. 1997..To evaluate the cost-effectiveness (CE) of new combined modality strategies in patients with stage III non-small-cell lung cancer (NSCLC)...
Thymidylate synthase expression in stage II and III colon cancer: a retrospective reviewA Tomiak
London Regional Cancer Centre, London, Ontario, Canada
Am J Clin Oncol 24:597-602. 2001..The lack of difference in outcome for patients with low and high TS receiving chemotherapy suggests that high TS levels may predict greater benefit from adjuvant treatment...
Marital status and survival following bladder cancerG Dabral Datta
Harvard School of Public Health, Department of Society, Human Development and Health, 677 Huntington Ave, Kresge Building 7 Floor, Boston, MA 02115, USA
J Epidemiol Community Health 63:807-13. 2009..Marital status has been implicated as a prognostic factor in bladder cancer survival. However, few studies have explored potential mechanisms through which this might occur...
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle
Dana Farber Cancer Institute, Boston, Massachusetts, USA
J Surg Oncol 100:525-8. 2009..Failing to meet the benchmark of 12 lymph nodes in resection specimens is an indication for adjuvant chemotherapy in stage II colon cancer...
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancerP C Enzinger
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Ann Oncol 20:475-80. 2009..Recent studies have examined the addition of docetaxel to fluorouracil and cisplatin in advanced esophagogastric cancer...
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancerJ A Meyerhardt
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Ann Oncol 18:1185-9. 2007..Targeting the epidermal growth factor receptor and angiogenesis have proven useful strategies against metastatic colorectal cancer. The benefit of combining inhibitors of both pathways is unknown...
Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare dataMichael E Stokes
i3 Innovus, Medford, MA, USA
Value Health 11:213-20. 2008..Assessing the value of these treatments is compromised by a paucity of data on the impact of recurrence on economic costs and survival. The purpose of this study was to shed light on these issues...
Trends in follow-up and preventive care for colorectal cancer survivorsClaire F Snyder
Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
J Gen Intern Med 23:254-9. 2008..As cancer patients transition from treatment to survivorship, the responsibility of primary care providers (PCPs) versus oncology specialists is unclear...
Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancerJames A Hayman
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 69:1001-7. 2007..The objective of this study was to examine the utilization patterns of palliative RT among elderly patients with Stage IV NSCLC and, in particular, to identify factors associated with its use...
Cancer survivorship research and guidelines: maybe the cart should be beside the horseCraig C Earle
J Clin Oncol 25:3800-1. 2007
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancerJeffrey A Meyerhardt
Dana Farber Cancer Institute, Boston, MA 02115, USA
Dig Dis Sci 53:564-70. 2008....
Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patientsEwout W Steyerberg
Center for Medical Decision Making, Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
J Clin Oncol 25:2389-96. 2007..Referring physicians and treating specialists must ensure that elderly patients are not deprived of the opportunity to consider all of their treatment options...
Methodological issues in the use of administrative claims data to study surveillance after cancer treatmentAnn Butler Nattinger
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Med Care 40:IV-69-74. 2002..Administrative claims databases linked to tumor registry data provide an excellent opportunity for studying the follow-up care of cancer patients...
Lower use of hospice by cancer patients who live in minority versus white areasJennifer S Haas
Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120 1613, USA
J Gen Intern Med 22:396-9. 2007..Although hospice care can alleviate suffering at the end of life for patients with cancer, it remains underutilized, particularly by African Americans and Hispanics...
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancerJeffrey A Meyerhardt
Dana Farber Cancer Institute, Boston, MA 02115, USA
Cancer Chemother Pharmacol 60:661-70. 2007....
Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancerMonika K Krzyzanowska
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Int J Radiat Oncol Biol Phys 67:211-8. 2007..Economic modeling can be used to explore the potential of such novel therapies and to inform clinical trial design...
Preventive care for colorectal cancer survivors: a 5-year longitudinal studyClaire F Snyder
Division of General Internal Medicine, Johns Hopkins School of Medicine, 624 N Broadway, Room 657, Baltimore, MD 21205, USA
J Clin Oncol 26:1073-9. 2008..To explore the mix of physician specialties that long-term survivors visit and how the mix relates to preventive care...
Racial segregation and disparities in cancer stage for seniorsJennifer S Haas
Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
J Gen Intern Med 23:699-705. 2008..Disparities in cancer survival may be related to differences in stage. Segregation may be associated with disparities in stage, particularly for cancers for which screening promotes survival...
Toward population-based indicators of quality end-of-life care: testing stakeholder agreementEva Grunfeld
Cancer Outcomes Research Program, Cancer Care Nova Scotia, Halifax, Nova Scotia
Cancer 112:2301-8. 2008..The objective of this study was to assess stakeholder acceptability of QIs of end-of-life (EOL) care that potentially were measurable from population-based administrative health databases...
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P Ryan
Gastrointestinal Cancer Center, Dana Farber Partners Cancer Care, Boston, Massachusetts, USA
Cancer 94:97-103. 2002..Chemotherapy with gemcitabine is the standard first-line treatment. In a Phase II trial at one academic cancer center, the clinical safety and activity of combining gemcitabine and docetaxel were assessed...
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs
Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Cancer 94:3186-91. 2002..A recent trial reported a moderate antitumor activity for gemcitabine among Asian patients with advanced hepatocellular carcinoma. This led to our examination of the efficacy and tolerability of the drug in a population of U.S. patients...
Racial segregation and disparities in breast cancer care and mortalityJennifer S Haas
Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02120 1613, USA
Cancer 113:2166-72. 2008..Questions have existed as to whether residential segregation is a mediator of racial/ethnic disparities in breast cancer care and breast cancer mortality, or has a differential effect by race/ethnicity...
Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancerChristopher S Lathan
Department of Medical Oncology, Division of Population Sciences, Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 26:4347-52. 2008..Our study examines the relationship between the percentage of black patients treated at a hospital to determine whether it affects the likelihood of obtaining cancer-directed surgery for patients with non-small-cell lung cancer (NSCLC)...
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?Craig C Earle
Division of Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
J Clin Oncol 26:3860-6. 2008..Whether the concept of overly aggressive treatment represents a quality-of-care issue that is acceptable to all involved stakeholders is an open question...
The outcomes and costs of acute myeloid leukemia among the elderlyJoseph Menzin
Boston Health Economics, Inc, 20 Fox Rd, Waltham, MA 02451, USA
Arch Intern Med 162:1597-603. 2002..The incidence of acute myeloid leukemia (AML) among the elderly can be expected to grow as the population continues to age. However, data on current treatment practices and costs for this form of cancer are sparse...
Measuring complications of cancer treatment using the SEER-Medicare dataArnold L Potosky
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 40:IV-62-8. 2002..One category of outcomes amenable to research using Medicare claims is complications of cancer treatments: the unintentional, adverse side effects or sequelae of interventions used to treat or palliate cancer patients...
Delays in referral and diagnosis for chronic hematologic malignancies: a literature reviewGregory A Abel
Department of Medical Oncology, Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
Leuk Lymphoma 49:1352-9. 2008..Unfortunately, the outcomes associated with such delays are largely unreported, possibly because delay is complex to define and difficult to measure...
Looking back from death: the value of retrospective studies of end-of-life careCraig C Earle
J Clin Oncol 24:838-40. 2006
Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodologyEva Grunfeld
Cancer Outcomes Research Program, Cancer Care Nova Scotia, Dalhousie University, Halifax, Canada
Palliat Med 20:769-77. 2006..Using administrative data is an efficient, population-based method to monitor quality of care which can compliment other methods, such as qualitative and purposefully collected clinical data...
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patientsJonathan E Lim
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
Ann Surg 237:74-85. 2003....
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guidelineCraig C Earle
Dana Farber Cancer Institute, Boston, Mass, USA
Can J Surg 45:438-46. 2002..To make recommendations on the use of neoadjuvant or adjuvant therapy in addition to surgery in patients with resectable gastric cancer (T1-4, N1-2, M0)...
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancerA David McCollum
Texas Oncology, PA, and Baylor Sammons Cancer Center, Dallas, TX 75246, USA
Am J Clin Oncol 29:40-4. 2006..We conducted a multicenter, phase II study to examine the combination of capecitabine and thalidomide (Cape/Thal) in patients with refractory metastatic CRC...
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancerDavid P Ryan
Dana Farber Partners Cancer Care Gastrointestinal Cancer Center, Brigham and Women s Hospital, Dana Farber Cancer Institute, Massachusetts General Hospital, Boston, Massachusetts, USA
Cancer Invest 21:505-11. 2003....
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Dig Dis Sci 50:2218-23. 2005..When used as a single-agent, a tri-weekly schedule may be preferable for this patient population...
The effect of race on invasive staging and surgery in non-small-cell lung cancerChristopher S Lathan
Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 24:413-8. 2006..They are more likely not to have surgery recommended, and more likely to refuse surgery. Additional research should focus on the physician-patient encounter as a potential source of racial disparities...
Trends in the treatment of acute myeloid leukaemia in the elderlyKathleen Lang
Boston Health Economics, Inc, Waltham, Massachusetts 02451, USA
Drugs Aging 22:943-55. 2005..Our findings can be used as a baseline against which the benefits of new therapies can be compared...
Patterns of care studies: creating "an environment of watchful concern"Craig C Earle
J Clin Oncol 21:4479-80. 2003
Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patientsEwout W Steyerberg
Department of Public Health, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands
J Clin Oncol 23:510-7. 2005..We investigated racial disparities in access to surgical evaluation, receipt of surgery, and survival among elderly patients with locoregional esophageal cancer...
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregiversEva Grunfeld
Ottawa Regional Cancer Centre and Division of Medical Oncology, University of Ottawa, and Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa Hospital, ON
CMAJ 170:1795-801. 2004..We prospectively examined the psychosocial, occupational and economic impact of caring for a person with a terminal illness...
Does reimbursement influence chemotherapy treatment for cancer patients?Mireille Jacobson
University of Michigan, Ann Arbor, USA
Health Aff (Millwood) 25:437-43. 2006..Providers who were more generously reimbursed, however, prescribed more-costly chemotherapy regimens to metastatic breast, colorectal, and lung cancer patients...
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt
Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 24:1892-7. 2006..To investigate the combination of erlotinib, capecitabine, and oxaliplatin in patients who were previously treated for metastatic colorectal cancer...
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancerAndrew X Zhu
Massachusetts General Hospital, 100 Blossom Street, Cox 640, Boston, MA 02114, USA
Cancer Chemother Pharmacol 59:285-93. 2007....
Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancerBrian M Wolpin
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
Clin Colorectal Cancer 6:208-13. 2006....
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)Elizabeth B Lamont
Massachusetts General Hospital Cancer Center and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
J Natl Cancer Inst 98:1335-8. 2006....
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk scoreEwout W Steyerberg
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
J Clin Oncol 24:4277-84. 2006..We aimed to develop and validate a simple risk score for surgical mortality that could be applied to administrative data...
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancerMichael J Hassett
Center for Outcomes and Policy Research, Dana Farber Cancer Institute, 44 Binney Street, 454 STE 21, Boston, MA 02115 6084, USA
J Natl Cancer Inst 98:1108-17. 2006..The number, nature, and costs of serious adverse effects experienced by younger women receiving chemotherapy for breast cancer outside of clinical trials are unknown...
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumorsMatthew H Kulke
Department of Medical Oncology, Dana Institute, Boston, Massachusetts, USA
Dig Dis Sci 51:1033-8. 2006..4 months. We conclude that while the combination of irinotecan and cisplatin may have activity in aggressive neuroendocrine tumor subtypes, this combination is inactive in patients with well-differentiated neuroendocrine tumors...
Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial informationRinaa S Punglia
Department of Radiation Oncology and Center for Outcomes and Policy Research, Division of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
J Clin Oncol 24:3474-82. 2006..We sought to study the receipt of PMRT in elderly women in this period, using a population-based cohort of women with breast cancer...
Do unto othersCraig C Earle
J Clin Oncol 24:3331-2. 2006
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly womenRinaa S Punglia
Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Int J Radiat Oncol Biol Phys 66:56-63. 2006..We sought to study the effect of distance to the nearest radiation treatment facility on the use of postmastectomy radiation therapy (PMRT) in elderly women...
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancerJeffrey A Meyerhardt
Dana Farber Cancer Institute, Brigham Women s Hospital, Boston, MA 02115, USA
Clin Colorectal Cancer 6:59-65. 2006..Whether these results apply to other cancer types is unknown but worthy of further study...
Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysisJoseph Menzin
Boston Health Economics, Inc, Waltham, Massachusetts, USA
Drugs Aging 21:737-46. 2004..To fill this void, our study uses population-based data to evaluate longer-term treatment patterns, outcomes and costs among elderly Medicare beneficiaries following their diagnosis of CML...
